Sumatriptan Tablet, Film Coated
Product Images NDC 69452-345

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 69452-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sumatriptan Figure 1)

Chemical Structure (Sumatriptan Figure 1)
Chemical structure of Sumatriptan, showing its molecular components including an indole ring, sulfonamide group, and carboxylic acid moiety with an associated ethylene glycol fragment.*
FDA Label Image

Figure 1 (Sumatriptan Figure 2)

Figure 1 (Sumatriptan Figure 2)
A line graph showing the estimated probability of response over time in minutes from the initial dose. It compares placebo with Sumatriptan tablets at 25 mg, 50 mg, and 100 mg doses. The graph depicts increasing response probabilities over 240 minutes for all doses, with active doses showing higher response rates than placebo over time.*
FDA Label Image

Figure 2 (Sumatriptan Figure 3)

Figure 2 (Sumatriptan Figure 3)
This is a line graph depicting the estimated probability of remediation or rescue over time in hours from the initial dose of Sumatriptan tablets at different strengths (25 mg, 50 mg, 100 mg) compared to placebo. The vertical axis shows probability in percentage from 0% to 100%, and the horizontal axis shows time in hours from 0 to 25 hours. The placebo group shows the highest probability increase, followed by the 25 mg, 50 mg, and 100 mg doses, respectively.*
FDA Label Image

25 mg Label (Sumatriptan Figure 4)

25 mg Label (Sumatriptan Figure 4)
Sumatriptan Tablets, USP 25 mg film-coated oral tablets packaging label. The label indicates the product contains 9 tablets per blister and includes storage instructions, manufacturer information for Bionpharma Inc., and distribution details. The label highlights that each tablet has 25 mg of sumatriptan and includes barcode and regulatory markings.*
FDA Label Image

50 mg Label (Sumatriptan Figure 5)

50 mg Label (Sumatriptan Figure 5)
Packaging label for Sumatriptan Tablets, USP 50 mg, film-coated tablets. The label indicates 9 film-coated tablets in 1 blister pack. It includes usage cautions, storage instructions, and blister opening directions. Manufactured by Bionpharma Inc., Princeton, NJ. The design highlights dosage strength and dispensing instructions for pharmacists.*
FDA Label Image

100 mg Label (Sumatriptan Figure 6)

100 mg Label (Sumatriptan Figure 6)
Packaging label for Sumatriptan Tablets, USP 100 mg film-coated tablets, oral administration. The label indicates each blister contains 9 tablets, with 1 blister per package. Labeler is Bionpharma Inc. The label includes usage instructions, storage conditions, and warnings, as well as barcodes and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.